Cincor pharma inc. stock price

Author: tbsv

August undefined, 2024

WebCINC Complete CinCor Pharma Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. WebFeb 23, 2024 · AstraZeneca announced today the successful completion of the acquisition of CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing novel treatments for resistant and uncontrolled hypertension as well as chronic kidney disease. The acquisition bolsters AstraZeneca's cardiorenal pipeline by …

CinCor Pharma Announces Pricing of Upsized Public Offering

WebAug 11, 2024 · The public offering price of each share of common stock is $30.00 and the public offering price of each pre-funded warrant is $29.99999 per underlying share, which represents the per share public ... WebApr 7, 2024 · CinCor Pharma Insiders Bought Stock Recently Over the last quarter, CinCor Pharma insiders have spent a meaningful amount on shares. In total, insiders bought US$279k worth of shares in that time ... shard peter pan tea

CinCor Pharma, Inc. Stock Price Today, CINC Stock Price Chart

WebWe explain how to buy CinCor Pharma Inc stock and compare the best stock trading platforms. Plus a detailed analysis for (CINC) and full financial history. ... CinCor … WebCinCor Pharma Inc is a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. ... Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS; $29.06: $29.20: $10.53 - $43.15: $1.27B: 43.8M: 738K-$2.43: CinCor Pharma ... WebThe CinCor Pharma, Inc. stock prediction for 2025 is currently $ 19.40, assuming that CinCor Pharma, Inc. shares will continue growing at the average yearly rate as they did … shard pixelmon

Amended Tender Offer Statement by Third Party (sc To-t/a)

CINCOR PHARMA, INC. Management

WebFeb 21, 2024 · WALTHAM, Mass., Feb. 21, 2024 -- CinCor Pharma, Inc. announced today completion of an End-of-Phase 2 meeting with the U.S. Food and Drug Administration on the anticipated Phase 3 program for... April 8, 2024 WebCinCor Pharma Inc. company facts, information and financial ratios from MarketWatch. ... 12/01 EU edges closer to imposing $60-a-barrel cap on Russian oil prices ... 12/01 Tesla stock ends flat ... shard physiotherapyWebCompany profile page for CinCor Pharma Inc including stock price, company news, press releases, executives, board members, and contact information shard pattern

"WebAug 15, 2024 · WALTHAM, Mass., Aug. 15, 2024 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”) (Nasdaq: CINC), a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate ... " - Cincor pharma inc. stock price

Cincor pharma inc. stock price

CINC - Cincor Pharma Stock Price - Barchart.com

WebCincor Pharma Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. WebJan 7, 2024 · add_box. BOSTON, Jan. 06, 2024 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”) (Nasdaq: CINC), a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate ...

Did you know?

WebTwo crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification. WebThe offer price of $26 a share represents a 121% premium to CinCor’s (ticker: CINC) closing price on Friday, ... CinCor Pharma Stock Surges on AstraZeneca Deal to Buy …

WebFind the latest stock market trends and activity today. Compare key indexes, including Nasdaq Composite, Nasdaq-100, Dow Jones Industrial & more. WebThe CinCor Pharma, Inc. stock prediction for 2025 is currently $ 19.40, assuming that CinCor Pharma, Inc. shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a -33.24% increase in the CINC stock price.

WebThe CINC stock price is closed at $ 29.06 with a total market cap valuation of $ 1.27B (44M shares outstanding). The CINC is trading on NASDAQ with the sign CINC. CINC price is … WebDec 6, 2024 · CinCor Pharma sheds 27% as blood pressure candidate fails in mid-stage study Seeking Alpha 11/28/2024 CinCor Pharma Inc. (CINC) Sits And Waits For …

WebJan 9, 2024 · Check out our CINC stock analysis, current CINC quote, charts, and historical prices for CinCor Pharma, Inc. - Common Stock stock

WebSep 14, 2024 · Insiders who bought CinCor Pharma, Inc. (NASDAQ:CINC) in the last 12 months may probably not pay attention to the stock's recent 5.5% drop. Reason being, despite the recent loss, insiders original ... poole to bath distanceWeb10. The Cincor Pharma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, … poole to bognor regis shard pilingWebJan 10, 2024 · CinCor Pharma Inc (CINC) stock is trading at $28.85 as of 12:42 PM on Tuesday, Jan 10, a rise of $0.10, or 0.37% from the previous closing price of $28.74. Volume today is 631,021 compared to average volume of 841,035. The stock has traded between $28.50 and $29.31 so far today. shard plate armorWebFeb 23, 2024 · CinCor Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing its lead clinical candidate, CIN-107, for the treatment … shard pieceWebCINC Nasdaq Stock Market • NLS real time price • CURRENCY IN USD • Biotechnology & Medical Research. CINCOR PHARMA, INC. CINCOR PHARMA, INC. 29.06 ... shardplateWebFeb 1, 2024 · CinCor shares ripped higher on Jan. 9 after pharma giant AstraZeneca PLC announced plans to buy CinCor at an upfront price of $1.3 billion, more than double the closing price of CinCor's shares the week before. Prior to the buyout announcement, CinCor's stock had plummeted 47% in a single day in November 2024 when baxdrostat … poole to bere regis